Life sciences company Thermo Fisher (NYSE:TMO) reported in Q3 CY2025, with sales up 4.9% year on year to $11.12 billion. Its ...

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump ...

Thermo Fisher Scientific Inc (TMO) reports robust financial performance with a 5% revenue increase and upwardly revised 2025 ...

Medical equipment maker Thermo Fisher beat analysts' estimates for third-quarter revenue and profit on Wednesday, owing to ...

Adjusted EPS in the third quarter of 2025 were $5.79, versus $5.28 in the third quarter of 2024. Adjusted operating income ...

Thermo Fisher (TMO) stock gains as the company beats Street forecasts with its Q3 2025 earnings results thanks to all-around ...

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its ...

Thermo Fisher Scientific Inc. (NYSE: TMO) announced AI utilization plans with OpenAI in a collaboration intended to improve ...

Thermo Fisher Scientific Inc (NYSE: TMO) reported better-than-expected earnings for the third quarter on Wednesday.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial ...

Read here for an analysis of Thermo Fisher (TMO) stock's Q3 2024 growth, major stock buyback, and how Fed rate cuts boost ...

Thermo Fisher Scientific Inc.TMO recently completed the buyout of Patheon N.V. Notably, Patheon is a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and ...